Dr. Yuehui Lin has over a decade of clinical experience in hematology, with a long-standing focus on the comprehensive management of leukemia through chemotherapy, immunotherapy, and cellular therapies. She has extensive practical experience in CAR-T cell therapy and is highly proficient in the full treatment pathway—including patient evaluation, therapeutic administration, and risk management. Dr. Lin has an in-depth understanding of the distinctions among various immunotherapeutic approaches and their optimal sequencing, including strategic bridging between immunotherapy, chemotherapy, and hematopoietic stem cell transplantation, enabling her to design precise, individualized treatment plans for complex hematologic cases.
With a strong foundation in hematologic diagnostics and specialized laboratory assessments, Dr. Lin demonstrates deep insight into disease mechanisms and diagnostic workflows. She excels at designing diagnostic pathways, assessing critical decision points, and performing comprehensive evaluations in challenging cases. Dr. Lin has actively contributed to the exploration of multiple therapeutic strategies, and her clinical experience and research findings have been presented at major international hematology conferences, reflecting her ongoing innovation and academic impact in the fields of leukemia and immune-based therapies.
